Medical specialists from Canada tagged as investigators in clinical trials studying Giant Cell Arteritis
Total 15 results
-
Carolyn Ross, MDSeen in:
- Quebec, Montreal, Vasculitis Clinic, Hopital du Sacre-Coeur de Montreal
Trials:- NCT05703763 (Sub-Investigator)
Conditions: -
Christian Pagnoux, MDSeen in:
- Ontario, Toronto, Mount Sinai Hospital
- Ontario, Toronto, Mount Sinai Hospital, Toronto
Trials:- NCT01241305 (Principal Investigator)
- NCT01940094 (Principal Investigator)
- NCT02108860 (Principal Investigator)
-
Christian PineauSeen in:
- Quebec, Montreal, McGill University
Trials:- NCT01066208 (Principal Investigator)
-
Jean-Paul Makhzoum, MDSeen in:
- Quebec, Montreal, Vasculitis Clinic, Hopital du Sacre-Coeur de Montreal
Trials:- NCT05703763 (Principal Investigator)
Conditions: -
Lillian BarraSeen in:
- Ontario, St Joseph's Healthcare London, Ontario
Trials:- NCT01066208 (Principal Investigator)
-
Michael WalshSeen in:
- Calgary, University of Calgary
Trials:- NCT01066208 (Principal Investigator)
-
Nader KhalidiSeen in:
- Ontario, Hamilton, St Joseph's Healthcare
- Ontario, Hamilton, St. Joseph's Healthcare
Trials:- NCT01066208 (Principal Investigator)
- NCT01241305 (Principal Investigator)
- NCT01940094 (Principal Investigator)
Conditions:- Giant Cell Arteritis;
- Wegener's Granulomatosis;
- Microscopic Polyangiitis;
- Polyarteritis Nodosa;
- Takayasu Arteritis;
- Churg Strauss Syndrome;
- Takayasu's Arteritis;
- Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss);
- Granulomatosis With Polyangiitis (Wegener's);
- Granulomatosis With Polyangiitis
-
Nataliya MilmanSeen in:
- Ontario, Ottawa, University of Ottawa
Trials:- NCT01066208 (Principal Investigator)
-
Navjot DhindsaSeen in:
- Manitoba, Winnipeg, University of Manitoba
Trials:- NCT01066208 (Principal Investigator)
-
Patrick LiangSeen in:
- Quebec, Sherbrooke, Sherbrooke University Hospital Centre
Trials:- NCT01066208 (Principal Investigator)
-
Remi Goupil, MD, MScSeen in:
- Quebec, Montreal, Vasculitis Clinic, Hopital du Sacre-Coeur de Montreal
Trials:- NCT05703763 (Sub-Investigator)
Conditions: -
Samer Hussein, MDSeen in:
- Quebec, Montreal, Vasculitis Clinic, Hopital du Sacre-Coeur de Montreal
Trials:- NCT05703763 (Sub-Investigator)
Conditions: -
Simon CaretteSeen in:
- Ontario, Toronto, Mount Sinai Hospital, Toronto
Trials:- NCT01066208 (Principal Investigator)
-
Stephanie Ducharme-Benard, MDSeen in:
- Quebec, Montreal, Vasculitis Clinic, Hopital du Sacre-Coeur de Montreal
Trials:- NCT05703763 (Sub-Investigator)
Conditions:
Clinical Trials on Giant Cell Arteritis
-
Matthew J KosterEli Lilly and CompanyCompleted
-
AbbVieActive, not recruitingGiant Cell Arteritis (GCA)United States, Australia, Austria, Belgium, Canada, Czechia, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Japan, Netherlands, New Zealand, Norway, Portugal, Romania, Russian Federation, Spain, Sweden, Switzerland, United...
-
University Hospital, Basel, SwitzerlandNovartis; Schweizerische Stiftung für die Erforschung der MuskelkrankheitenRecruitingPolymyalgia Rheumatica (PMR) | Giant Cell Arteritis (GCA)Switzerland
-
University Hospital, GrenobleTerminated
-
Novartis PharmaceuticalsRecruitingGiant Cell Arteritis (GCA)United States, Israel, Spain, Turkey, France, Hungary, Belgium, Germany, Argentina, Chile, Greece, Portugal, Bulgaria, Italy, Switzerland, Australia, Czechia, Denmark, Austria, Brazil, Guatemala, United Kingdom, Finland, Russian Federation and more
-
Centre Hospitalier Universitaire DijonRecruitingPatients Relapsing Refractory Giant Cell ArteritisFrance
-
University Hospital, LimogesTerminatedGiant Cell Arteritis in Dependency of ElderlyFrance
-
University Health Network, TorontoCompleted
-
Centre Hospitalier Universitaire de NiceUnknownArteritis, Giant Cell | Blindness and Low VisionFrance
-
University of OxfordUniversity of LeedsWithdrawnTemporal Arteritis